Clinical Trial Update: A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating TNFerade Biologic with 5-FU and radiation therapy as first-line treatment for unresectable locally advanced pancreatic cancer has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• TNFerade Biologic (TNFerade)

Snippet

Sponsor: GenVec | Conditions: Pancreatic Cancer | Phase 3 | Status: COMPLETED